Accord Healthcare
Barnstaple generic-medicines manufacturer; received over \xC2\xA345m LSIMF grant, April 2026.
Last refreshed: 22 April 2026 · Appears in 1 active topic
Why does the UK's largest LSIMF award go to an Indian-owned company in Devon?
Timeline for Accord Healthcare
Received over £45m for generic medicine manufacturing in Barnstaple
UK Startups and Innovation: LSIMF sends £80m+ to four regional sites- What does Accord Healthcare make in Barnstaple?
- Accord Healthcare's Barnstaple facility manufactures generic and biosimilar medicines, including injectables and oral solid-dosage forms, for distribution in over 90 countries. It received over £45m from DSIT's LSIMF in April 2026.Source: DSIT / Lowdown
- Who owns Accord Healthcare?
- Accord Healthcare is wholly owned by Intas Pharmaceuticals, one of India's largest generic pharmaceutical groups.
Background
Accord Healthcare's Barnstaple manufacturing facility received over £45m from DSIT's Life Sciences Innovative Manufacturing Fund on 14 April 2026, the largest single award in the current LSIMF round . The grant is intended to expand sterile-manufacturing capacity and modernise the site's aseptic fill-finish lines.
Accord Healthcare is a UK-based generic and biosimilar medicines manufacturer, wholly owned by Intas Pharmaceuticals of India, one of the world's largest generic pharma groups. Accord's Barnstaple plant is one of the largest generic-medicine manufacturing facilities in the UK, producing injectable and oral solid-dosage forms for distribution in over 90 countries.
The LSIMF award signals government confidence in retaining high-value pharmaceutical manufacturing in South West England. Barnstaple's grant alone exceeds the combined awards to three other LSIMF sites, making Accord the programme's anchor investment.